In search of novel agents for therapy of tropical diseases and human immunodeficiency virus

Journal of Medicinal Chemistry

Volumn 51, Issue 2, 2008, Pages 238-250

  Goebel, Tim ^a   Ulmer, Daniela ^a   Projahn, Holger ^a   Kloeckner, Jessica ^a   Heller, Eberhard ^a   Glaser, Melanie ^a,b   Ponte Sucre, Alicia ^a,b   Specht, Sabine ^c   Sarite, Salem Ramadan ^c   Hoerauf, Achim ^c   Kaiser, Annette ^d   Hauber, Ilona ^e   Hauber, Joachim ^e   Holzgrabe, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c UNIVERSITY OF BONN   (Germany)

^d BONN RHEIN SIEG UNIVERSITY OF APPLIED SCIENCES   (Germany)

^e LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIETHYLPIPERIDONE 3,5 DICARBOXYLATE DERIVATIVE; 4 [(2,6 DICHLOROBENZYLOXYIMINO)METHYL] 1 (3 PHENYLPROPYL)PIPERIDINIUM; AMPHOTERICIN B; CHLOROQUINE; DIETHYL 1 ALLYL 4 HYDROXY 2,6 BIS(4 NITROPHENYL) 1,2,3,6 TETRAHYDROPYRIDINE 3,5 DICARBOXYLATE; DIETHYL 1 BENZYL 4 HYDROXY 2,6 BIS(4 NITROPHENYL) 1,2,3,6 TETRAHYDROPYRIDINE 3,5 DICARBOXYLATE; PIPERIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RESEARCH; DRUG SCREENING; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; MACROPHAGE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; TROPICAL DISEASE; TRYPANOSOMA BRUCEI; VIRUS INHIBITION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTIMALARIALS; CELL LINE; ETHERS; HIV-1; HUMANS; LEISHMANIA MAJOR; MACROPHAGES; MICE; MICE, INBRED C57BL; OXIMES; PIPERIDINES; PLASMODIUM FALCIPARUM; SPIRO COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; VIRUS REPLICATION;

EID: 38349138801     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070763y     Document Type: Article

References (53)

1. Greenwood, B. M.; Bojang, K.; Whitty, C. J. M.; Targett, G. A. T. Malaria. Lancet 2005, 365, 1487-1498.
2. See the following Web sites: http://www.who.int/tdr/diseases/tryp/, http://www.who.int/tdr/diseases/chagas/diseaseinfo.htm, and http://www.who.int/ leishmaniasis/en/.
3. D'Silva, C. Human African trypanosomiasis: future propects for chemotherapy. Drugs Future 2007, 32, 149-160.
4. Projan, S. J. Why is big Pharma getting out of antibacterial drug discovery? Curr. Op. Microbiol. 2003, 6, 427-430.
5. Nwaka, S.; Hudson, A. Innovative lead discovery strategies for tropical diseases. Nat. Drug Discovery 2006, 5, 941-955.
6. Müller, S.; Da'dara, A.; Lürsen, K.; Wrenger, C.; Das Gupta, R.; Madhubala, R.; Walter, R. D. In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase. J. Biol. Chem. 2000, 275, 8097-8102.
7. Haider, N.; Eschbach, M. L.; Dias Sde, S.; Gilberger, T. W.; Walter, R. D.; Luersen, K. The spermidine synthase of the malaria parasite Plasmodium falciparum: molecular and biomchemical characterization of the polyamine synthesis enzyme. Mol. Biochem. Parasitol. 2005, 142, 224-236.
8. Casero, R. A., Jr.; Marton, L. J. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nature Rev. Drug Discovery 2007, 7, 373-390.
9. Das Gupta, R.; Krause-Ihle, T.; Bergmann, B.; Muller, I. B.; Khomutov, A. R.; Müller, S.; Walter, R. D; Luersen, K. 3-Aminooxy-1-aminopropane and derivatives have an antiproliferative effect on cultured Plasmodium falciparum by decreasing intracellular polyamine concentrations. Antimicrob. Agents Chemother. 2005, 49, 2857-2864.
10. Kaiser, A.; Gottwald, A.; Wiersch, C.; Lindenthal, B.; Maier, W.; Seitz, H. M. Effect of drugs inhibiting spermidine biosynthesis and metabolism on the in vitro development of Plasmodium falciparum. Parasitol. Res. 2001, 87, 963-972.
11. Park, M. H.; Wolff, E. C.; Folk, J. E. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential in cellular regulation. BioFactors 1993, 4, 95-104.
12. Abbruzzese, A.; Park, M. H.; Folk, J. E. Deoxyhypusine hydroxylase from rat testis. Partial purification and characterization. J. Biol. Chem. 1988, 261, 3085-3089.
13. Park, M. H.; Wolff, E. C. Cell-free synthesis of deoxyhypusine. Separation of protein substrate and enzyme and identification of 1,3diaminopropane as a product of spermidine cleavage. J. Biol. Chem. 1988, 263, 15264-15269.
14. Njuguna, J. T.; Nassar, M.; Hoerauf, A.; Kaiser, A. E. Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax. BMC Microbiol. 2006, 6, 91.
15. Clement, P. M.; Hanauske-Abel, H. M.; Wolff, E. C.; Kleinmann, H. K.; Park, M. H. The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogensis in vitro. Int. J. Cancer 2002, 100, 491-498.
16. Saeftel, M.; Sarite, R. S.; Njuguna, T.; Holzgrabe, U.; Ulmer, D.; Hoerauf, A.; Kaiser, A. Piperidones with activity against Plasmodium falciparum. Parasitol. Res. 2006, 99, 281-286.
17. Dong, Z.; Arnold, R.; Yang, Y.; Park, M. H.; Hrncirova, P.; Mechref, Y.; Novotny, M. V.; Zhang, J. T. Modulation of differentiation-related gene-1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol. Cell. Proteomics 2005, 4, 993-1001.
18. Park, M. H. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF-5A). J. Biochem. 2006, 139, 1-9.
19. Du Moulinet d'Hardemare, A.; Torelli, S.; Serratrice, G.; Pierre, L.-L. Design of iron chelators: synthesis and iron(III) complexing abilities of tripodal tris-bidentate ligands. BioMetals 2006, 19, 349-366.
20. Cotton, F. A.; Wilkinson, G. Advanced Inorganic Chemistry, 5th ed.; Wiley: New York, 1988, p 710.
21. Haller, R. Metallchelate pyridyl-(2)-substituierter piperidone und piperidinole (Metal chelates of substituted piperidones and piperidinoles). Arch. Pharm. 1968, 301, 741-749.
22. Bevec, D.; Jaksche, H.; Oft, M.; Wohl, T.; Himmelspach, M.; Pacher, A.; Schebesta, M.; Koettnitz, K.; Dobrovnik, M.; Csonga, R.; Lottspeich, F.; Hauber, J. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 1996, 271, 1858-1860.
23. Schäfer, B.; Hauber, I.; Bunk, A.; Heukeshoven, J.; Düsedau, A.; Bevec, D.; Hauber, J. Inhibition of multi-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity. J. Infect. Dis. 2006, 194, 740-750.
24. Hauber, I.; Bevec, D.; Heukeshoven, J.; Krätzer, F.; Horn, F.; Choidas, A.; Harrer, T.; Hauber, J. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J. Clin. Invest. 2005, 115, 76-85.
25. Hart, R. A.; Billaud, J. N.; Choi, S. J.; Phillips, T. R. Effects of 1,8-diaminooctane on the FIV Rev regulatory system. Virology 2002, 304, 97-104.
26. Andrus, L.; Szabo, P.; Grady, R. W.; Hanauske, A.-R.; Huima-Byron, T.; Slowinska, B.; Zagulska, S.; Hanauske-Abel, H. M. Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors. Biochem. Pharmacol. 1998, 55, 1807-1818.
27. Kaiser, A.; Ulmer, D.; Goebel, T.; Holzgrabe, U.; Saeftel, M.; Hoerauf, A. Inhibition of hypusine biosynthesis in plasmodium: a possible, new startegy in prevention and therapy of malaria. Mini-Rev. Med. Chem. 2006, 6, 1231-1241.
28. Merz, K. W.; Haller, R. Synthesen mit Pyridin- und Chinolinaldehyden (Synthesis with pyridine- and quinolinealdehyde). Pharm. Acta Helv. 1963, 38, 442-456.
29. Ashauer-Holzgrabe, U.; Haller, R. Zur Umsetzung von N-benzylsubstituierten Piperidoncarbonsäuren mit Cer(IV)sulfat (Conversion N-benzyl substituted piperidoncarboxylic acid with cerium(IV) sulfate). Arch. Pharm. (Weinheim, Ger.) 1986, 319, 1079-1083.
30. Kuhl, U.;Englberger, W.; Haurand, M.; Holzgrabe, U. Diazabicyclo[3.3.1]- nonanone-type ligands for the opioid receptors. Arch. Pharm. 2000, 333, 226-230.
31. Holzgrabe, U.; Piening, B.; Kohlmorgen, R.; Stoll, E. Synthese verschieden substituierter 5-Oxo-2,6-methano-2-benzazocines (Synthesis of differently substituted 5-Oxo-2,6-methano-2-benzazocines). Arch. Pharm. (Weinheim, Ger.) 1988, 321, 917-920.
32. Siener, T.; Holzgrabe, U.; Drosihn, S.; Brandt, W. Conformational and configurational behaviour of κ-agonistic 3,7-diazabicyclo-[3.3.1]nonan-9- ones - synthesis, nuclear magnetic resonance studies and semiempirical PM3 calculations. J. Chem. Soc., Perkin Trans. 1999, 2, 1827-1834.
33. Smith, M. B.; March, J. March's Advanced Organic Chemistry, 5th ed.; Wiley-Interscience: New York, 2001; p 1240.
34. Röver, S.; Adam, G.; Cesura, A. M.; Galley, G.; Jenck, F.; Monsma, F. J.; Wichmann, J.; Dautzenberg, F. M. High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor. J. Med. Chem. 2000, 43, 1329-1338.
35. Bisset, D. L.; McBride, J. F. Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen. J. Am. Acad. Dermatol. 1996, 35, 546-549.
36. Pais, G. C. G.; Burke, T. R. Novel aryl diketo-containing inhibitors of HIV-1 integrase. Drugs Future 2002, 27, 1101-1111.
37. Holzgrabe, U.; Hoerr, V. Unpublished results.
38. Kang, K. R.; Kim, Y. S.; Wolff, E. C.; Park, M. H. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor interaction. J. Biol. Chem. 2007, 282, 8300-8308.
39. Holzgrabe, U.; Erciyas, E. Synthese und Stereochemie potentiell stark analgetischer 2,4-m-diarylsubstituierter 3,7-diazabicyclo[3.3.1]nonan-9-on-1,5- diester (Synthesis and stereochemistry of the potentially strong analgesic 2,4-m-diaryl-substituted 3,7-diazabicyclo[3.3.1]nonan-9-on-1,5-diester). Arch. Pharm. (Weinheim. Ger.) 1992, 325, 657-663.
40. Holzgrabe, U.; Piening, B.; Hesse, K.-F.; Höltje, H.-D.; Worch, M. Stereochemistry of 2,6-dipyridine substituted N-benzyl-4-piperidone mono- and dicarboxylates and the corresponding reduction products. Z. Naturforsch. 1988, 44b, 565-574.
41. Haller, R.; Kohlmorgen, R. Synthese und Struktur substituierter N-Benzyl-piperidoncarbonsäureester (Synthesis and structure of substituted N-benzyl-piperidoncarboxylic acid ester). Arch. Pharm. (Weinheim, Ger.) 1976, 309, 206-214.
42. Haller, R. Zur Synthese 2,6-disubstituierter Piperidonmonocarbonsä ureester (On the synthesis of 2,6-substituted piperidone monocarboxylic acid esters). Arch. Pharm. 1965, 298, 787-794.
43. Holzgrabe, U.; Piening, B.; Kohlmorgen, R.; Stoll, E. Cer(IV)oxidationen von β-Aminoketonen. 5. Mitt. Synthese verschieden substituierter 5-Oxo-2,6-methano-2-benzazocine (Cerium(IV) oxidation of β-Aminoketones. 5. Synthesis of differently substituted 5-Oxo-2,6-methano-2-benzazocines). Arch. Pharm. (Weinheim, Ger.) 1988, 321, 917-920.
44. van Parys, M.; Vandewalle, M. The synthesis of 1,8-diazaspiro[4,4] decanes. Bull. Soc. Chim. Belg. 1981, 90, 749-756.
45. Taber, D. F.; Rahimizadeh, M. Amide to ester conversion: a practical route to the carfentanil class of analgetics. J. Org. Chem. 1992, 57, 4037-4038.
46. Trager, W.; Williams, J. Extracellular (axenic) development in vitro of the erythrocytic cycle of Plasmodium falciparum. Proc. Nat. Acad. Sci. U.S.A. 1992, 89, 5351-5355.
47. Moloney, M. B.; Pawluk, A. R.; Ackland, N. R. Plasmodium falciparum growth in deep culture. Trans. R. Soc. Trop. Med. Hyg. 1990, 84, 516-518.
48. Singh, S.; Puri, S. K.; Singh, S. K.; Srivastava, R.; Das Gupta, R. C.; Pandey, V. C. Characterization of simian malarial parasite (Plasmodium knowlesi)-induced putrescine transport in rhesus monkey erythrocytes. A novel putrescine conjugate arrests in vitro growth of simian malarial parasite (Plasmodium knowlesi) and cures multidrug resistant murine malaria (Plasmodium yoelii) infection in vivo. J. Biol. Chem. 1997, 272, 13506-13511.
49. Räz, B.; Iten, M.; Grether-Bühler, Y.; Kaminsky, R.; Brun, R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. brucei rhodesiense and T. brucei gambiense) in vitro. Acta Trop. 1997, 68, 139-147.
50. 50 in studies of drug resistance of malaria parasites. Acta Trop. 1993, 55, 257-261.
51. Baltz, T.; Baltz, D.; Giroud, C.; Crocket, J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 1985, 4, 1273-1277.
52. 3H]thymidine incorporation assay. J. Immunol. Methods 1994, 170, 211-224.
53. Ponte-Sucre, A.; Vicik, R.; Schultheis, M.; Schirmeister, T.; Moll, H. Aziridine-2,3-dicarboxylates: peptidomimetic cysteine protease inhibitors with antileishmanial activity. Antimicrob. Agents Chemother. 2006, 50, 2439-2447.